Briefly: Investments in Pepscope, Kive, XCD and Kinomica

Pepscope is a Dutch biotechnology company offering innovative endogenous protein kinase activity profiling technologies. Today, Pepscope announces a 4.3-million-euro funding round, led by KIKK Capital, together with Oost NL and the Netherlands Enterprise Agency to further develop and commercialize her lead product QuantaKinome™.

___________________________________________________________________________

‚Deals in Europe‘

Private Equity Investments in Europe

  • 14-daily publication with ALL Private Equity Deals in Europe
  • With every ‚Deals in Europe‘ issue you will receive an update of ALL deals from the respective year as an Excel file
  • Detailed information of target, investors, buyer, seller and advisors

More information / EXAMPLE edition of ‚Deals in Europe‘

____________________________________________________________________________

BGF has invested £2 million in XCD, the cloud-based HR and Payroll software provider, to support its organic and acquisitive growth strategy. Founded in 2011, XCD has grown to have over 30,000 users across 35 countries benefitting from its range of Salesforce powered services.

___________________________

BGF announces investment in North West life sciences business, Kinomica. North West-based proteomic-data science and diagnostics company, Kinomica, has secured £3.9 million in funding for pioneering technology that could prove integral to the development of new drug treatments.

___________________________

Kive has raised €1.5 million in funding co-led by EQT Ventures and Creandum. The company is planning to use the funding to strengthen the team across Europe and iterate on the product. The Swedish company targets filmmakers, designers, photographers, architects, fashion stylists, publishers, and e-commerce brands.